Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of regional inequalities in access to molecular radiotherapy services; and what plans they have to reduce inequalities in access to those services.

Based on information provided by National Health Service trusts, there are 38 providers of this service in England, spread across each of the seven NHS regions.

As part of the implementation process of the new standalone service specification for molecular radiotherapy (MRT), which is expected from April 2024, work will be undertaken to confirm the nature and type of MRT services being provided by trusts and allow for access considerations to be taken into account.